-
1
-
-
70349213313
-
Guidelines for the diagnosis and management of aplastic anaemia
-
Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147(1):43-70.
-
(2009)
Br J Haematol
, vol.147
, Issue.1
, pp. 43-70
-
-
Marsh, J.C.1
Ball, S.E.2
Cavenagh, J.3
Darbyshire, P.4
Dokal, I.5
Gordon-Smith, E.C.6
-
2
-
-
33750628439
-
Current concepts in the pathophysiology and treatment of aplastic anemia
-
Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108(8):2509-19.
-
(2006)
Blood
, vol.108
, Issue.8
, pp. 2509-2519
-
-
Young, N.S.1
Calado, R.T.2
Scheinberg, P.3
-
3
-
-
0031030329
-
Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle bone marrow transplant team
-
Doney K, Leisenring W, Storb R, Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med. 1997; 126(2):107-15.
-
(1997)
Ann Intern Med
, vol.126
, Issue.2
, pp. 107-115
-
-
Doney, K.1
Leisenring, W.2
Storb, R.3
Appelbaum, F.R.4
-
4
-
-
78649910213
-
Acquired aplastic anemia and Fanconi anemia
-
In: Barrett J, Trealeaven J, editors
-
Gupta V, Marsh J. Acquired aplastic anemia and Fanconi anemia. In: Barrett J, Trealeaven J, editors. Practical Stem Cell Transplantation. 2009;165-77.
-
(2009)
Practical Stem Cell Transplantation
, pp. 165-177
-
-
Gupta, V.1
Marsh, J.2
-
5
-
-
58149090759
-
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
-
Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol. 2009;144(2):206-16.
-
(2009)
Br J Haematol
, vol.144
, Issue.2
, pp. 206-216
-
-
Scheinberg, P.1
Wu, C.O.2
Nunez, O.3
Young, N.S.4
-
6
-
-
50549104303
-
Treatment strategies for patients with severe aplastic anemia
-
Bacigalupo A. Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplant. 2008;42 (Suppl 1):S42-4.
-
(2008)
Bone Marrow Transplant
, vol.42
, Issue.1 SUPPL.
, pp. 42-44
-
-
Bacigalupo, A.1
-
8
-
-
12944332070
-
Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy - the European Group for Blood and Marrow Transplantation experience
-
Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J, et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy - the European Group for Blood and Marrow Transplantation experience. Semin Hematol. 2000;37(1):69-80.
-
(2000)
Semin Hematol
, vol.37
, Issue.1
, pp. 69-80
-
-
Bacigalupo, A.1
Brand, R.2
Oneto, R.3
Bruno, B.4
Socie, G.5
Passweg, J.6
-
9
-
-
17444452424
-
Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the european group for blood and marrow transplantation. on behalf of the working party on severe aplastic anemia of the European group for blood and marrow transplantation
-
Bacigalupo A, Oneto R, Bruno B, Socie G, Passweg J, Locasciulli A, et al. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation. Acta Haematol. 2000;103(1):19-25.
-
(2000)
Acta Haematol
, vol.103
, Issue.1
, pp. 19-25
-
-
Bacigalupo, A.1
Oneto, R.2
Bruno, B.3
Socie, G.4
Passweg, J.5
Locasciulli, A.6
-
10
-
-
12144289116
-
Long-term outcome after bone marrow transplantation for severe aplastic anemia
-
Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004;103(7): 2490-7.
-
(2004)
Blood
, vol.103
, Issue.7
, pp. 2490-2497
-
-
Ades, L.1
Mary, J.Y.2
Robin, M.3
Ferry, C.4
Porcher, R.5
Esperou, H.6
-
11
-
-
33846898991
-
Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: A report from the European Group for Blood and Marrow Transplantation (EBMT)
-
Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2007;92(1):11-8.
-
(2007)
Haematologica
, vol.92
, Issue.1
, pp. 11-18
-
-
Locasciulli, A.1
Oneto, R.2
Bacigalupo, A.3
Socie, G.4
Korthof, E.5
Bekassy, A.6
-
12
-
-
70349148649
-
Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabinebased conditioning: A comparison with conventional conditioning regimen
-
Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, Socie G, et al. Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabinebased conditioning: a comparison with conventional conditioning regimen. Haematologica. 2009;94(9):1312-5.
-
(2009)
Haematologica
, vol.94
, Issue.9
, pp. 1312-1315
-
-
Maury, S.1
Bacigalupo, A.2
Anderlini, P.3
Aljurf, M.4
Marsh, J.5
Socie, G.6
-
13
-
-
48949116752
-
Graft-versushost disease following marrow transplantation for aplastic anemia: Different impact of two GVHD prevention strategies
-
Siegal D, Xu W, Sutherland R, Kamel-Reid S, Kuruvilla J, Lipton JH, et al. Graft-versushost disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplant. 2008;42(1):51-6.
-
(2008)
Bone Marrow Transplant
, vol.42
, Issue.1
, pp. 51-56
-
-
Siegal, D.1
Xu, W.2
Sutherland, R.3
Kamel-Reid, S.4
Kuruvilla, J.5
Lipton, J.H.6
-
14
-
-
10344221138
-
Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti- CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia
-
Gupta V, Ball SE, Yi QL, Sage D, McCann SR, Lawler M, et al. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti- CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Biol Blood Marrow Transplant. 2004;10(12): 867-76.
-
(2004)
Biol Blood Marrow Transplant
, vol.10
, Issue.12
, pp. 867-876
-
-
Gupta, V.1
Ball, S.E.2
Yi, Q.L.3
Sage, D.4
McCann, S.R.5
Lawler, M.6
-
15
-
-
0029029246
-
Consensus Conference on Acute GVHD Grading
-
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825-8.
-
(1994)
Bone Marrow Transplant
, vol.15
, Issue.6
, pp. 825-828
-
-
Przepiorka, D.1
Weisdorf, D.2
Martin, P.3
Klingemann, H.G.4
Beatty, P.5
Hows, J.6
-
17
-
-
0033616908
-
Estimation of failure probabilities in the presence of competing risks: New representations of old estimators
-
Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;30;18(6):695-706.
-
(1999)
Stat Med
, vol.18-30
, Issue.6
, pp. 695-706
-
-
Gooley, T.A.1
Leisenring, W.2
Crowley, J.3
Storer, B.E.4
-
19
-
-
0037420270
-
Antithymocyte globulin and cyclosporine for severe aplastic anemia: Association between hematologic response and long-term outcome
-
Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003; 289(9):1130-5.
-
(2003)
JAMA
, vol.289
, Issue.9
, pp. 1130-1135
-
-
Rosenfeld, S.1
Follmann, D.2
Nunez, O.3
Young, N.S.4
-
20
-
-
0037441586
-
Antithymocyte globulin with or without cyclosporin A: 11-year follow- up of a randomized trial comparing treatments of aplastic anemia
-
Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H. Antithymocyte globulin with or without cyclosporin A: 11-year follow- up of a randomized trial comparing treatments of aplastic anemia. Blood. 2003;101(4):1236-42.
-
(2003)
Blood
, vol.101
, Issue.4
, pp. 1236-1242
-
-
Frickhofen, N.1
Heimpel, H.2
Kaltwasser, J.P.3
Schrezenmeier, H.4
-
21
-
-
0027360514
-
Malignant tumors occurring after treatment of aplastic anemia. European bone marrow transplantation-severe aplastic anaemia working party
-
Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993; 329(16):1152-7.
-
(1993)
N Engl J Med
, vol.329
, Issue.16
, pp. 1152-1157
-
-
Socie, G.1
Henry-Amar, M.2
Bacigalupo, A.3
Hows, J.4
Tichelli, A.5
Ljungman, P.6
-
22
-
-
15544377256
-
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning
-
Gupta V, Ball SE, Sage D, Ortin M, Freires M, Gordon-Smith EC, et al. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant. 2005;35(5):467-71.
-
(2005)
Bone Marrow Transplant
, vol.35
, Issue.5
, pp. 467-471
-
-
Gupta, V.1
Ball, S.E.2
Sage, D.3
Ortin, M.4
Freires, M.5
Gordon-Smith, E.C.6
-
23
-
-
34347375339
-
Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia
-
George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia. Bone Marrow Transplant. 2007;40(1):13-8.
-
(2007)
Bone Marrow Transplant
, vol.40
, Issue.1
, pp. 13-18
-
-
George, B.1
Mathews, V.2
Viswabandya, A.3
Kavitha, M.L.4
Srivastava, A.5
Chandy, M.6
-
24
-
-
10744233646
-
Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection
-
Dulley FL, Vigorito AC, Aranha FJ, Sturaro D, Ruiz MA, Saboya R, et al. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection. Bone Marrow Transplant. 2004;33(1):9-13.
-
(2004)
Bone Marrow Transplant
, vol.33
, Issue.1
, pp. 9-13
-
-
Dulley, F.L.1
Vigorito, A.C.2
Aranha, F.J.3
Sturaro, D.4
Ruiz, M.A.5
Saboya, R.6
-
25
-
-
33646671932
-
Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine- based preparative regimen
-
Resnick IB, Aker M, Shapira MY, Tsirigotis PD, Bitan M, Abdul-Hai A, et al. Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine- based preparative regimen. Br J Haematol. 2006;133(6):649-54.
-
(2006)
Br J Haematol
, vol.133
, Issue.6
, pp. 649-654
-
-
Resnick, I.B.1
Aker, M.2
Shapira, M.Y.3
Tsirigotis, P.D.4
Bitan, M.5
Abdul-Hai, A.6
-
26
-
-
0033168009
-
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry
-
Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341(1):14-21.
-
(1999)
N Engl J Med
, vol.341
, Issue.1
, pp. 14-21
-
-
Socie, G.1
Stone, J.V.2
Wingard, J.R.3
Weisdorf, D.4
Henslee-Downey, P.J.5
Bredeson, C.6
|